| Title |
Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
|
|---|---|
| Published in |
ClinicoEconomics and Outcomes Research: CEOR, September 2013
|
| DOI | 10.2147/ceor.s47990 |
| Pubmed ID | |
| Authors |
Ken O’Day, Krithika Rajagopalan, Kellie Meyer, Andrei Pikalov, Antony Loebel |
| Abstract |
The purpose of this study was to evaluate the long-term cost-effectiveness (including hospitalizations and cardiometabolic consequences) of atypical antipsychotics among adults with schizophrenia. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Chile | 1 | 1% |
| Colombia | 1 | 1% |
| Unknown | 92 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 17% |
| Student > Master | 13 | 14% |
| Other | 10 | 11% |
| Student > Ph. D. Student | 10 | 11% |
| Student > Bachelor | 8 | 9% |
| Other | 19 | 20% |
| Unknown | 18 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 26 | 28% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 10% |
| Economics, Econometrics and Finance | 7 | 7% |
| Nursing and Health Professions | 6 | 6% |
| Agricultural and Biological Sciences | 5 | 5% |
| Other | 17 | 18% |
| Unknown | 24 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 June 2016.
All research outputs
#8,098,676
of 25,728,855 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#183
of 527 outputs
Outputs of similar age
#65,915
of 213,399 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#6
of 16 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 527 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 213,399 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.